SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001104659-23-111352
Filing Date
2023-10-25
Accepted
2023-10-25 13:43:51
Documents
1
Effectiveness Date
2023-10-25

Document Format Files

Seq Description Document Type Size
1 15-12G tm2329128d1_1512g.htm 15-12G 11864
  Complete submission text file 0001104659-23-111352.txt   12967
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-37558 | Film No.: 231344975
SIC: 2834 Pharmaceutical Preparations